aripiprazole has been researched along with citalopram in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (16.36) | 29.6817 |
| 2010's | 33 (60.00) | 24.3611 |
| 2020's | 13 (23.64) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Sen, S; Sinha, N | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Bojarski, AJ; Duszyńska, B; Grychowska, K; Jastrzębska-Więsek, M; Lenda, T; Marciniec, K; Maślankiewicz, A; Nowak, G; Partyka, A; Pawłowski, M; Satała, G; Siwek, A; Wesołowska, A; Wróbel, D; Zajdel, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bucki, A; Gryboś, A; Głuch-Lutwin, M; Jastrzębska-Więsek, M; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Partyka, A; Pawłowski, M; Pytka, K; Siwek, A; Śniecikowska, J; Wesołowska, A; Więckowski, K | 1 |
| He, Y; Liu, Y; Shen, J; Shi, W; Wang, Y; Wang, Z; Wu, C; Wu, S; Yang, F; Zheng, W | 1 |
| Padala, KP; Padala, PR; Sadiq, HJ | 1 |
| Demirdaş, A; Eren, I; Naziroğlu, M | 1 |
| Brahm, NC; Brown, RC; McElwain, DL | 1 |
| Klein, J; Krüger, S; Sarkar, R | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Denninger, JW; Dording, C; Fava, M; Hilliker, S; Homberger, C; Matthews, JD; Park, L; Rooney, K; Siefert, C; Sklarsky, K; van Nieuwenhuizen, AO | 1 |
| Butters, MA; Dew, MA; Driscoll, HC; Lenze, EJ; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Sheffrin, M | 1 |
| Blier, P; Chernoloz, O; El Mansari, M | 1 |
| Hedlund, PB; Roberts, AJ; Sarkisyan, G | 1 |
| Anghelescu, I; Born, C; Langosch, J; Luborzewski, A; Quante, A; Schommer, N; Wolf, J; Zeugmann, S | 1 |
| Greenway, LL; Kuppuswamy, PS; Lauterbach, EC | 1 |
| Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z | 1 |
| Bundgaard, C; Garmer, M; Jensen, CJ | 1 |
| Bou Khalil, R; Dahdah, P; Kahn, DA; Richa, S | 1 |
| Pomeraniec, F; Primeau, M; Wallace, DM | 1 |
| Dimitrakopoulos, S; Kollias, K; Konstantakopoulos, G; Oulis, P; Tsaltas, E | 1 |
| Choi, JE; Han, DH; Kim, SM; Min, KJ; Renshaw, PF | 1 |
| Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A | 1 |
| Banerjee, R; Liu, JJ; Minhas, HM | 1 |
| Chibnall, JT; Conway, CR; Cornell, ME; Cumming, P; Gangwani, S; Gebara, MA; McConathy, JE; Mintun, MA; Perantie, DC; Price, JL; Sheline, YI | 1 |
| Yalcin, O | 1 |
| Chen, TT; Huang, WL; Tsai, CH | 1 |
| Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS | 1 |
| Andrews, G; Boulton, M; Michael, S | 1 |
| Hou, YC; Lai, CH | 1 |
| Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Suzuki, T | 1 |
| Beslow, LA; Ghoshal, S; Guo, XM; Schilsky, ML; Schindler, EA; Schrag, M | 1 |
| Alonso, E; Arnott, SR; Atluri, S; Blumberger, D; Brenner, CA; Daskalakis, ZJ; Dhami, P; Dharsee, M; Evans, KR; Farzan, F; Frehlich, M; Frey, BN; Kennedy, SH; Kleffner, K; Lam, RW; Liotti, M; McAndrews, MP; Milev, R; Price, R; Ravindran, A; Rotzinger, S; Vila-Rodriguez, F; Wong, W | 1 |
| Hudson, R; Leri, F; Zhou, Y | 1 |
| Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Allen, TA; Frey, BN; Kennedy, SH; Lam, RW; MacQueen, GM; Milev, R; Müller, DJ; Quilty, LC; Rizvi, SJ; Uher, R | 1 |
| Blier, P; Downar, J; Evans, KR; Farzan, F; Foster, JA; Frey, BN; Giacobbe, P; Hall, GB; Harkness, KL; Hassel, S; Ismail, Z; Kennedy, SH; Lam, RW; Leri, F; MacQueen, GM; McInerney, S; Milev, RV; Minuzzi, L; Müller, DJ; Parikh, SV; Placenza, FM; Quilty, LC; Ravindran, AV; Rotzinger, S; Sassi, RB; Soares, CN; Strother, SC; Turecki, G; Uher, R; Vaccarino, AL; Vila-Rodriguez, F; Yu, J | 1 |
| Cheng, X; Dong, W; Feng, W; Li, H; Wang, M; Zhang, D | 1 |
| Balcı, N; Demir, Y; Gürbüz, M; Küfrevioğlu, Öİ; Özaslan, MS | 1 |
| Alders, GL; Arnott, SR; Davis, A; Frey, BN; Hall, GB; Harris, J; Hassel, S; Kennedy, SH; Lam, RW; MacQueen, GM; Milev, R; Minuzzi, L; Raamana, PR; Sassi, RB; Strother, SC; Suh, JS; Zamyadi, M | 1 |
| Białoń, M; Hereta, M; Kamińska, K; Lorenc-Koci, E; Rogóż, Z; Wąsik, A | 1 |
| Blier, P; Foster, JA; Frey, BN; Kennedy, SH; Lam, RW; MacQueen, G; Milev, R; Müller, DJ; Parikh, SV; Quilty, LC; Ravindran, AV; Rotzinger, S; Soares, CN; Turecki, G; Uher, R | 1 |
| Mishra, VC; Swami, MK | 1 |
| Kennedy, SH; Lam, RW; Uher, R | 1 |
| Chen, A; Cloutier, A; Copeli, F; Metzger, E; Osser, DN | 1 |
| Bhat, V; Chakrabarty, T; Frey, BN; Giacobbe, P; Kennedy, SH; Lam, RW; Lou, W; Michalak, EE; Milev, RV; Morton, E; Müller, DJ; Parikh, SV; Rotzinger, S | 1 |
| Bhat, V; Diep, C; Frey, BN; Gandhi, W; Kennedy, SH; Khoo, Y; Ladha, KS; Lam, RW; Lou, W; Milev, RV; Ravindran, AV; Rosenek, N; Rotzinger, S; Salomons, T; van Reekum, CM | 1 |
| Jauhar, S; Kaufman, KR; Kerr-Gaffney, J; Kurana, S; Strawbridge, R; Yalin, N; Young, AH | 1 |
| Ait Chait, Y; Hammami, R; Mottawea, W; Tompkins, TA | 1 |
| Lu, Z; Wang, Y; Xun, G | 1 |
5 review(s) available for aripiprazole and citalopram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A systematic review of medical treatments for children with autism spectrum disorders.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome | 2011 |
Lycanthropy as a culture-bound syndrome: a case report and review of the literature.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior Control; Citalopram; Cultural Characteristics; Culture; Delusions; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Ethnopsychology; Female; Humans; Lebanon; Middle Aged; Mythology; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2012 |
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia.
Topics: Academic Medical Centers; Aged; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Citalopram; Dementia; Electroconvulsive Therapy; Haloperidol; Humans; Olanzapine; Psychopharmacology; Risperidone | 2021 |
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder.
Topics: Aripiprazole; Bipolar Disorder; Citalopram; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2022 |
12 trial(s) available for aripiprazole and citalopram
| Article | Year |
|---|---|
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Feasibility Studies; Female; Humans; Male; Personality Inventory; Pilot Projects; Piperazines; Quinolones; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Aripiprazole; Bipolar Disorder; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.
Topics: Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Antipsychotic Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Functional Neuroimaging; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurons; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Selective Serotonin Reuptake Inhibitors | 2013 |
Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.
Topics: Adult; Animals; Antidepressive Agents; Aripiprazole; Caudate Nucleus; Citalopram; Corpus Striatum; Depressive Disorder, Major; Dihydroxyphenylalanine; Dopamine; Dopamine Agonists; Drug Synergism; Female; Humans; Magnetic Resonance Imaging; Male; Piperazines; Positron-Emission Tomography; Quinolones; Sample Size; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
Effects of escitalopram on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients.
Topics: Adult; Aripiprazole; Asian People; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Electrocardiography; Electroencephalography; Female; Genotype; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Piperazines; Quinolones | 2014 |
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Aripiprazole; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Treatment Outcome; Young Adult | 2019 |
An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
Topics: Adult; Antidepressive Agents; Aripiprazole; Cerebral Cortex; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Outcome Assessment, Health Care | 2020 |
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Aripiprazole; Citalopram; Depressive Disorder, Major; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Lethargy; Male; Middle Aged; Young Adult | 2020 |
Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report.
Topics: Antidepressive Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Escitalopram; Humans; Pain; Pain Measurement; Treatment Outcome | 2022 |
Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: A randomized controlled trial.
Topics: Antidepressive Agents; Aripiprazole; Citalopram; Cognition; Depression; Depressive Disorder, Major; Double-Blind Method; Escitalopram; Humans; Treatment Outcome | 2024 |
38 other study(ies) available for aripiprazole and citalopram
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Isoquinolines; Mice; Molecular Structure; Motor Activity; Piperazines; Quinolines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Structure-Activity Relationship; Sulfonamides | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.
Topics: Affect; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Dementia; Dopamine Agonists; Drug Design; Humans; Indoles; Ligands; Models, Molecular; Pyridines; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists | 2017 |
Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychotics.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Structure-Activity Relationship; Triazoles | 2020 |
Urinary obstruction with citalopram and aripiprazole combination in an elderly patient.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Citalopram; Drug Therapy, Combination; Humans; Male; Piperazines; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Urinary Retention | 2006 |
Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Ascorbic Acid; beta Carotene; Brain; Calcium Channel Blockers; Citalopram; Glutathione; Glutathione Peroxidase; Lamotrigine; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Piperazines; Quinolones; Random Allocation; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Triazines; Vitamin A | 2007 |
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; Diphenhydramine; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Hypnotics and Sedatives; Male; Mental Disorders; Oxazepam; Piperazines; Quinolones | 2007 |
Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
Topics: Antipsychotic Agents; Aripiprazole; Chronic Disease; Citalopram; Drug Therapy, Combination; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior | 2008 |
An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Selective Serotonin Reuptake Inhibitors | 2009 |
Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.
Topics: Action Potentials; Analysis of Variance; Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Brain; Citalopram; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Lysergic Acid Diethylamide; Male; Neurons; Norepinephrine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Time Factors | 2009 |
The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Corticosterone; Depression; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenols; Piperazines; Quinolones; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides; Swimming | 2010 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors | 2010 |
Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Citalopram; Cyclohexanols; Gene Knockout Techniques; Genotype; Mice; Piperazines; Quinolones; Rats; Risperidone; Species Specificity; Venlafaxine Hydrochloride | 2012 |
Serotonin toxicity in aripiprazole augmentation.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Cyproheptadine; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2012 |
Low-dose aripiprazole in the treatment of SSRI-induced bruxism.
Topics: Antipsychotic Agents; Aripiprazole; Bruxism; Citalopram; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2012 |
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid | 2013 |
Lyme neuroborreliosis presenting with alexithymia and suicide attempts.
Topics: Adult; Affective Symptoms; Anti-Bacterial Agents; Antibodies, Bacterial; Antipsychotic Agents; Aripiprazole; Borrelia; Ceftriaxone; Citalopram; Hospitalization; Humans; Injections, Intravenous; Intelligence Tests; Interview, Psychological; Lyme Neuroborreliosis; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Outcome | 2013 |
Micturition difficulty and urinary retention associated with aripiprazole and citalopram treatment in a male adolescent with Asperger syndrome.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Citalopram; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Urinary Retention; Urination Disorders | 2014 |
Combination of escitalopram and aripiprazole causes significant improvement of negative symptoms of simple schizophrenia.
Topics: Aripiprazole; Citalopram; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Quinolones; Schizophrenia; Treatment Outcome | 2014 |
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2014 |
Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Citalopram; Delusions; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Young Adult | 2014 |
Rapid responses of high-dose combined therapy of escitalopram and aripiprazole in a case of severe obsessive compulsive disorder with delusion.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Delusions; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Young Adult | 2014 |
Neuropsychiatric Presentation of Wilson Disease in an Adolescent Male.
Topics: Adenosine Triphosphatases; Adolescent; Aggression; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Brain; Cation Transport Proteins; Citalopram; Copper-Transporting ATPases; Depression; Diplopia; Dysarthria; Esophageal and Gastric Varices; Hepatolenticular Degeneration; Humans; Hypertension, Portal; Impulsive Behavior; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Mutation; Suicidal Ideation | 2016 |
Standardization of electroencephalography for multi-site, multi-platform and multi-investigator studies: insights from the canadian biomarker integration network in depression.
Topics: Access to Information; Antidepressive Agents; Aripiprazole; Brain Mapping; Canada; Citalopram; Data Curation; Depressive Disorder; Electroencephalography; Guidelines as Topic; Humans; Medical Informatics Computing; Problem Solving; Research Design; Research Personnel; Treatment Outcome | 2017 |
The combination of escitalopram and aripiprazole: Investigation of psychomotor effects in rats.
Topics: Animals; Aripiprazole; Brain-Derived Neurotrophic Factor; Citalopram; Drug Synergism; Eating; Hippocampus; Hypothalamus; Locomotion; Male; Pro-Opiomelanocortin; Psychomotor Performance; Rats; Stereotyped Behavior | 2017 |
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hyperkinesis; Male; Memory Disorders; Mianserin; Mice; Mirtazapine; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology | 2018 |
Early change in reward and punishment sensitivity as a predictor of response to antidepressant treatment for major depressive disorder: a CAN-BIND-1 report.
Topics: Adolescent; Adult; Anhedonia; Antidepressive Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Punishment; Reward; Young Adult | 2019 |
A UPLC-MS/MS Assay for Simultaneous Determination of Two Antipsychotics and Two Antidepressants in Human Plasma and Its Application in Clinic.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Chromatography, High Pressure Liquid; Citalopram; Drug Monitoring; Fluoxetine; Humans; Risperidone; Tandem Mass Spectrometry | 2020 |
Inhibition effects of some antidepressant drugs on pentose phosphate pathway enzymes.
Topics: Antidepressive Agents; Aripiprazole; Citalopram; Erythrocytes; Glucosephosphate Dehydrogenase; Haloperidol; Humans; Mirtazapine; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase | 2019 |
Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex.
Topics: Animals; Antidepressive Agents; Aripiprazole; Benzazepines; Biogenic Monoamines; Citalopram; Dizocilpine Maleate; Dopamine Antagonists; Frontal Lobe; Memory Disorders; Piperazines; Pyridines; Rats; Recognition, Psychology; Serotonin Antagonists | 2020 |
Interest-Activity Dimension and Response to Aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Humans; Quinolones | 2020 |
Dr Uher and Colleagues Reply.
Topics: Aripiprazole; Citalopram; Depressive Disorder, Major; Humans | 2020 |
Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report.
Topics: Aripiprazole; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Quality of Life; Treatment Outcome | 2021 |
Evidence of the Dysbiotic Effect of Psychotropics on Gut Microbiota and Capacity of Probiotics to Alleviate Related Dysbiosis in a Model of the Human Colon.
Topics: Aripiprazole; Citalopram; Colon; Dysbiosis; Gastrointestinal Microbiome; Humans; Probiotics; Psychotropic Drugs | 2023 |